SYENSQO 66.500 € (+1,60 %) AEDIFICA 71.550 € (+0,63 %) AB INBEV 71.900 € (+0,67 %) GIMV 49.500 € (+0,30 %) ACKERMANS V.HAAREN 274.000 € (+0,51 %) GBL 81.000 € (+1,12 %) ARGENX SE 701.000 € (-0,74 %) COLRUYT 33.460 € (+0,36 %) MATERIALISE 5.100 € (+4,08 %) COFINIMMO 84.050 € (+1,57 %) WDP 22.020 € (-2,05 %) AZELIS GROUP 10.310 € (-0,48 %) VASTNED 29.500 € (0,00 %) KBC 112.600 € (+2,04 %) SOLVAY 26.000 € (+2,04 %) LOTUS BAKERIES 10 840.000 € (-0,91 %) KBC ANCORA 79.200 € (+1,93 %) FAGRON 25.000 € (0,00 %) ONTEX GROUP 2.660 € (-3,27 %) TESSENDERLO 21.400 € (-0,23 %) ECONOCOM GROUP 1.550 € (+3,33 %) NYXOAH 2.450 € (+1,24 %) IMMOBEL 21.800 € (0,00 %) HOME INVEST BE. 18.940 € (-0,32 %) DEME GROUP 187.000 € (-0,85 %) TUBIZE-FIN 207.800 € (0,00 %) XIOR 27.300 € (+1,30 %) CARE PROPERTY INV. 13.180 € (-0,15 %) CENERGY 24.020 € (+0,08 %) BANQUP GROUP 2.450 € (+3,38 %) BARCO 9.145 € (+1,55 %) UMICORE 26.180 € (+5,74 %) QRF 11.650 € (+2,19 %) UCB 242.000 € (+0,46 %) VAN DE VELDE 30.700 € (+0,66 %) SOFINA 223.800 € (+0,54 %) VIOHALCO 19.060 € (-2,16 %) MELEXIS 81.450 € (+6,12 %) WAREHOUSES ESTATES 40.000 € (-0,25 %) TITAN S.A. 47.860 € (+1,27 %) JENSEN-GROUP 76.400 € (-0,78 %) CIE BOIS SAUVAGE 313.000 € (-1,26 %) FLUXYS BELGIUM D 19.850 € (-1,73 %) PROXIMUS 6.900 € (-0,29 %) CMB.TECH 14.580 € (-3,19 %) RECTICEL 10.720 € (+1,32 %) BEKAERT 41.450 € (+2,47 %) ASCENCIO 49.950 € (-1,09 %) MONTEA 67.000 € (+0,60 %) AGFA-GEVAERT 0.460 € (-0,43 %) ELIA GROUP 137.600 € (-0,51 %) BIOTALYS 2.880 € (-2,70 %) D'IETEREN GROUP 167.500 € (+2,13 %) SIPEF 95.200 € (+1,28 %) IBA 15.380 € (-1,03 %) NEXTENSA 46.000 € (+1,09 %) RETAIL ESTATES 70.000 € (+1,30 %) AGEAS 68.100 € (+0,52 %) KINEPOLIS GROUP 29.300 € (-1,84 %) EVS BROADC.EQUIPM. 31.150 € (-15,01 %)
RIBER 15.360 € (+16,54 %)
NN GROUP 75.840 € (+0,42 %)
VALLOUREC 24.040 € (-0,33 %)
RELX 28.380 € (-0,77 %)
DBV TECHNOLOGIES 3.182 € (-0,44 %)
SAINT GOBAIN 75.280 € (+1,67 %)
TIKEHAU CAPITAL 17.900 € (+2,52 %)
COFACE 16.440 € (+0,80 %)
UNIBAIL-RODAMCO-WE 97.600 € (-0,06 %)
WENDEL 88.900 € (+0,91 %)
LVMH 472.600 € (-0,20 %)
STMICROELECTRONICS 57.930 € (+5,17 %)
OPMOBILITY 15.300 € (+2,20 %)
GECINA 72.350 € (-0,48 %)
AIR FRANCE -KLM 10.255 € (+1,64 %)
ABN AMRO BANK N.V. 33.940 € (+1,65 %)
BASIC-FIT 29.900 € (-0,33 %)
DSM FIRMENICH AG 71.500 € (+0,25 %)
GTT 204.800 € (+0,59 %)
ADYEN 957.900 € (+1,58 %)
AMUNDI 85.700 € (-0,12 %)
METROPOLE TV 11.500 € (-0,17 %)
CARREFOUR 17.090 € (-1,07 %)
IPSEN 160.200 € (-0,25 %)
SODEXO 45.640 € (+0,13 %)
NOVACYT 0.580 € (+0,87 %)
ID LOGISTICS GROUP 362.500 € (-0,41 %)
ROCHE BOBOIS 25.600 € (-3,40 %)
ATOS 43.680 € (+7,22 %)
SES 8.950 € (+1,36 %)
2CRSI 46.700 € (+3,73 %)
NANOBIOTIX 36.460 € (+8,77 %)
FORVIA 10.375 € (+3,13 %)
AMG 38.640 € (+3,76 %)
SHELL PLC 37.110 € (-0,92 %)
AIRBUS 169.520 € (+2,15 %)
TRIGANO 153.600 € (-0,07 %)
BNP PARIBAS ACT.A 89.930 € (+0,86 %)
VIEL ET COMPAGNIE 18.900 € (+0,11 %)
ASR NEDERLAND 65.760 € (+1,20 %)
AALBERTS NV 38.760 € (+3,75 %)
REMY COINTREAU 40.600 € (-0,93 %)
VALEO 12.640 € (+2,39 %)
VICAT 61.800 € (+1,98 %)
ABIVAX 105.900 € (+0,76 %)
TOTALENERGIES 78.650 € (-2,01 %)
TELEPERFORMANCE 72.200 € (-1,45 %)
EKINOPS 3.100 € (+8,01 %)
ASML HOLDING 1 409.000 € (+4,74 %)
MERCIALYS 11.960 € (0,00 %)
QUADIENT 12.340 € (+3,01 %)
ALTEN 62.850 € (+1,05 %)
BILENDI 13.800 € (+0,29 %)
PHILIPS KON 23.370 € (+0,65 %)
CRCAM SUD R.A.CCI 245.500 € (+0,61 %)
AXA 40.120 € (+0,02 %)
KAUFMAN ET BROAD 25.050 € (+1,01 %)
WOLTERS KLUWER 62.500 € (-0,83 %)
L'OREAL 361.650 € (+0,61 %)
DANONE 61.860 € (-1,59 %) News Réglementées
|
22/05/2026 09:00
Original-Research: NFON AG (von NuWays AG): BUYOriginal-Research: NFON AG - from NuWays AG Classification of NuWays AG to NFON AG
Q1 in line with muted expectations Yesterday, NFON published its Q1'26 figures. Revenue and profitability came in soft, as widely expected given the subdued macro backdrop. In detail: Another transitional quarter. Q1 sales were down 2.3% yoy to € 21.6m (eNuW: € 22.4m). This was primarily attributable to continued seat erosion, with the base declining 3.1% yoy to 641k, as weak order intake and selective customer losses in the legacy PBX segment more than offset growth in AI solution. Importantly, the revenue mix held up well with recurring revenues remaining strong at 93.8% of total, and blended ARPU edged up to € 10.04 (Q1'25: € 10.02), reflecting the positive mix shift towards premium and AI-based solutions as well as prior pricing measures. What is particularly notable from the earnings call are the geographic differences: while Germany and the UK remain under pressure, Austria and Italy are showing significantly positive trends in both seats and revenues, suggesting the weakness is not broad-based. Margin compression is a deliberate investment, not a cost control failure. Adj. EBITDA of € 1.8m (eNuW: € 2.6m) was down 32% yoy, with the margin compressing to 8.3% (-3.5pp yoy). The gap is explained by two concurrent forces. One being the declining top line and the other an intentional step-up in personnel costs (+3.9% yoy) as NFON continues to build out its AI and product development capabilities under the NFON Next 2027 programme. In our view however, the company is well equipped to absorb this investment phase given a solid liquidity base and continued FCF generation (€ 1.6m in Q1). Further, we expect communicated cost measures to become increasingly visible from H2 onwards. AI traction is building. Customer Engagement and Intelligent Assistant together now account for c. 10% of sales, both growing at more than 10% yoy. This is a meaningful step up yet underappreciated by the market given the headline seat decline. The productive release of NFON's own Text-to-Speech AI service, built on the botario team's expertise and featuring EU-only data processing, is a further tangible proof of innovation speed and technological independence. While management was explicit on yesterday's call that growth is expected to return from Q3, a broader monetisation of AI solutions remains challenging, which is however not NFON specific but observed across the industry. Q2 is expected to remain muted, with H2 likely showing first tangible effects. We view FY26 as transitionary year, with the commercial and financial payoff of the AI build-out to materialise meaningfully from 2027 onwards. FY guidance confirmed at low-to-mid single-digit growth and >€ 12m adj. EBITDA. Growth looks reasonable despite the weak Q1 based on an expected normalisation of order intake in the partner channel, and the progressive contribution from AI-driven upsell as penetration of the existing customer base deepens. The EBITDA target requires a meaningful H2 step-up, which we regard as ambitious, yet achievable. Valuation remains attractive at 5.3x FY26e EV/adj. EBITDA for a cash generating business with strong recurring revenues. BUY, € 8.30 PT. You can download the research here: nfon-ag-2026-05-22-previewreview-en-5175e For additional information visit our website: https://www.nuways-ag.com/research Contact for questions: NuWays AG - Equity Research Web: www.nuways-ag.com Email: research@nuways-ag.com LinkedIn: https://www.linkedin.com/company/nuwaysag Adresse: Mittelweg 16-17, 20148 Hamburg, Germany ++++++++++ Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte. Offenlegung möglicher Interessenkonflikte nach § 85 WpHG beim oben analysierten Unternehmen befindet sich in der vollständigen Analyse. ++++++++++ The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. 2331914 22.05.2026 CET/CEST Source : Webdisclosure.com |
||||||||||||||||||
© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière